Is it possible to reduce the rate of vertical transmission and improve perinatal outcomes by inclusion of remdesivir in treatment regimen of pregnant women with COVID–19?

Is it possible to reduce the rate of vertical transmission and improve perinatal outcomes by inclusion of remdesivir in treatment regimen of pregnant women with COVID–19?

Abstract Background Coronavirus disease 2019 (COVID–19) is currently one of the world's most critical health issues so far. Given the importance of appropriate treatment in pregnancy and the controversies about Remdesivir effectiveness and complications, the present study aimed to evaluate the...

Full description

Bibliographic Details
Main Authors: Nader Tavakoli, Shahla Chaichian, Jamileh Sadat Sadraei, Saeedeh Sarhadi, Sepideh Arbabi Bidgoli, Elnaz Rokhsat, Katayoon Anoushirvani, Banafsheh Nikfar, Abolfazl Mehdizadehkashi
Format: Article
Language:English
Published: BMC 2023-02-01
Series:BMC Pregnancy and Childbirth
Subjects:
COVID–19
Pregnant women
Remdesivir
Neonatal
Vertical transmission
Pregnancy outcome
Online Access:https://doi.org/10.1186/s12884-023-05405-y

Internet

https://doi.org/10.1186/s12884-023-05405-y

Similar Items